Phase II study for bevacizumab combined with S-1 and raltitrexed in the treatment of metastatic colorectal cancer resistant to 5-fluorouracil / oxaliplatin /irinotecan
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
Interventions: Case series:bevacizumab combined with S-1 and raltitrexed Primary outcome(s): ORR Study Design: Non randomized control
创建时间：
2015-09-15
